Prson Gautam

2.5k total citations
22 papers, 921 citations indexed

About

Prson Gautam is a scholar working on Molecular Biology, Computational Theory and Mathematics and Oncology. According to data from OpenAlex, Prson Gautam has authored 22 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Computational Theory and Mathematics and 4 papers in Oncology. Recurrent topics in Prson Gautam's work include Computational Drug Discovery Methods (10 papers), Bioinformatics and Genomic Networks (7 papers) and Melanoma and MAPK Pathways (3 papers). Prson Gautam is often cited by papers focused on Computational Drug Discovery Methods (10 papers), Bioinformatics and Genomic Networks (7 papers) and Melanoma and MAPK Pathways (3 papers). Prson Gautam collaborates with scholars based in Finland, United States and Denmark. Prson Gautam's co-authors include Krister Wennerberg, Tero Aittokallio, Pipsa Saharinen, Kari Alitalo, Harri Nurmi, Veli‐Matti Leppänen, Johanna Ivaska, Tuomas Sipilä, Lauri Eklund and Guillaume Jacquemet and has published in prestigious journals such as Nature, Nature Communications and Hepatology.

In The Last Decade

Prson Gautam

22 papers receiving 908 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prson Gautam Finland 15 538 210 172 155 119 22 921
Claudia Eichler-Jonsson Sweden 3 712 1.3× 137 0.7× 173 1.0× 125 0.8× 96 0.8× 5 947
Ivan V. Ozerov United States 20 699 1.3× 272 1.3× 293 1.7× 188 1.2× 32 0.3× 34 1.3k
Pedro Casado United Kingdom 17 833 1.5× 89 0.4× 187 1.1× 161 1.0× 36 0.3× 45 1.2k
Xiang Zhuang China 13 441 0.8× 109 0.5× 54 0.3× 146 0.9× 79 0.7× 37 753
Bertram Klinger Germany 15 764 1.4× 99 0.5× 295 1.7× 227 1.5× 34 0.3× 29 1.1k
Vinothini Rajeeve United Kingdom 15 486 0.9× 63 0.3× 146 0.8× 113 0.7× 64 0.5× 37 823
Aurélien Dugourd Germany 15 930 1.7× 48 0.2× 154 0.9× 201 1.3× 80 0.7× 26 1.4k
Brent M. Kuenzi United States 13 524 1.0× 190 0.9× 331 1.9× 109 0.7× 14 0.1× 22 923
Christophe Frémin France 15 650 1.2× 29 0.1× 201 1.2× 107 0.7× 100 0.8× 17 1.0k
Vasileios Stathias United States 10 388 0.7× 200 1.0× 85 0.5× 93 0.6× 18 0.2× 21 644

Countries citing papers authored by Prson Gautam

Since Specialization
Citations

This map shows the geographic impact of Prson Gautam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prson Gautam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prson Gautam more than expected).

Fields of papers citing papers by Prson Gautam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prson Gautam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prson Gautam. The network helps show where Prson Gautam may publish in the future.

Co-authorship network of co-authors of Prson Gautam

This figure shows the co-authorship network connecting the top 25 collaborators of Prson Gautam. A scholar is included among the top collaborators of Prson Gautam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prson Gautam. Prson Gautam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ianevski, Aleksandr, Jenni Lahtela, Komal Kumar Javarappa, et al.. (2021). Patient-tailored design for selective co-inhibition of leukemic cell subpopulations. Science Advances. 7(8). 27 indexed citations
2.
Pulkkinen, Otto, Prson Gautam, Ville Mustonen, & Tero Aittokallio. (2020). Multiobjective optimization identifies cancer-selective combination therapies. PLoS Computational Biology. 16(12). e1008538–e1008538. 8 indexed citations
3.
Gupta, Abhishekh, Prson Gautam, Krister Wennerberg, & Tero Aittokallio. (2020). A normalized drug response metric improves accuracy and consistency of anticancer drug sensitivity quantification in cell-based screening. Communications Biology. 3(1). 42–42. 24 indexed citations
4.
Gautam, Prson, et al.. (2020). Systematic mapping of cancer cell target dependencies using high-throughput drug screening in triple-negative breast cancer. Computational and Structural Biotechnology Journal. 18. 3819–3832. 6 indexed citations
5.
Julkunen, Heli, Anna Cichońska, Prson Gautam, et al.. (2020). Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects. Nature Communications. 11(1). 6136–6136. 75 indexed citations
6.
Ianevski, Aleksandr, Anil K. Giri, Prson Gautam, et al.. (2019). Prediction of drug combination effects with a minimal set of experiments. Nature Machine Intelligence. 1(12). 568–577. 106 indexed citations
7.
Tang, Jing, Prson Gautam, Abhishekh Gupta, et al.. (2019). Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer. npj Systems Biology and Applications. 5(1). 20–20. 28 indexed citations
8.
Gautam, Prson, Alok Jaiswal, Tero Aittokallio, Hassan Al‐Ali, & Krister Wennerberg. (2019). Phenotypic Screening Combined with Machine Learning for Efficient Identification of Breast Cancer-Selective Therapeutic Targets. Cell chemical biology. 26(7). 970–979.e4. 33 indexed citations
9.
Gautam, Prson, Alok Jaiswal, Tero Aittokallio, Hassan Al‐Ali, & Krister Wennerberg. (2018). Phenotypic Screening Combined with Machine Learning for Efficient Identification of Breast Cancer-Selective Therapeutic Targets. SSRN Electronic Journal. 1 indexed citations
10.
Vaseva, Angelina V., Devon R. Blake, Thomas S.K. Gilbert, et al.. (2018). KRAS Suppression-Induced Degradation of MYC is Antagonized by a MEK5-ERK5 Compensatory Mechanism. SSRN Electronic Journal. 2 indexed citations
11.
Nepal, Chirag, Colm J. O’Rourke, Douglas V.N.P. Oliveira, et al.. (2017). Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma. Hepatology. 68(3). 949–963. 92 indexed citations
12.
Gautam, Prson. (2017). Chemical Systems Biology Studies of Triple Negative Breast Cancer Cell Lines. Työväentutkimus Vuosikirja. 1 indexed citations
13.
Mpindi, John Patrick, Bhagwan Yadav, Päivi Östling, et al.. (2016). Consistency in drug response profiling. Nature. 540(7631). E5–E6. 56 indexed citations
14.
Gautam, Prson, Leena Karhinen, Agnieszka Szwajda, et al.. (2016). Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells. Molecular Cancer. 15(1). 34–34. 52 indexed citations
15.
Duellman, Sarah, Wenhui Zhou, Poncho Meisenheimer, et al.. (2015). Bioluminescent, Nonlytic, Real-Time Cell Viability Assay and Use in Inhibitor Screening. Assay and Drug Development Technologies. 13(8). 456–465. 52 indexed citations
16.
Sipilä, Tuomas, Veli‐Matti Leppänen, Prson Gautam, et al.. (2015). Endothelial destabilization by angiopoietin-2 via integrin β1 activation. Nature Communications. 6(1). 5962–5962. 213 indexed citations
17.
Szwajda, Agnieszka, Prson Gautam, Leena Karhinen, et al.. (2015). Systematic Mapping of Kinase Addiction Combinations in Breast Cancer Cells by Integrating Drug Sensitivity and Selectivity Profiles. Chemistry & Biology. 22(8). 1144–1155. 16 indexed citations
18.
Al‐Ali, Hassan, Do-Hun Lee, Matt C. Danzi, et al.. (2015). Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth. ACS Chemical Biology. 10(8). 1939–1951. 53 indexed citations
19.
Vidugirienė, Jolanta, Donna Leippe, Gediminas Vidugiris, et al.. (2014). Bioluminescent Cell-Based NAD(P)/NAD(P)H Assays for Rapid Dinucleotide Measurement and Inhibitor Screening. Assay and Drug Development Technologies. 12(9-10). 514–526. 27 indexed citations
20.
Tuuminen, Raimo, Antti I. Nykänen, Pipsa Saharinen, et al.. (2013). Donor Simvastatin Treatment Prevents Ischemia-Reperfusion and Acute Kidney Injury by Preserving Microvascular Barrier Function. American Journal of Transplantation. 13(8). 2019–2034. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Eichler-Jonsson Breakdown of academic impact, for papers by Ivan V. Ozerov Breakdown of academic impact, for papers by Pedro Casado Breakdown of academic impact, for papers by Xiang Zhuang Breakdown of academic impact, for papers by Bertram Klinger Breakdown of academic impact, for papers by Vinothini Rajeeve Breakdown of academic impact, for papers by Aurélien Dugourd Breakdown of academic impact, for papers by Brent M. Kuenzi Breakdown of academic impact, for papers by Christophe Frémin Breakdown of academic impact, for papers by Vasileios Stathias
Rankless by CCL
2026